Label-independent detection of unpurified analytes

• US 7,349,080 B2
• Filed: 12/30/2004
• Issued: 03/25/2008
• Est. Priority Date: 12/30/2004
• Status: Expired due to Fees

• Current Assignee: Corning Incorporated
• Original Assignee: Corning Incorporated
• Inventors: Aklian, Mannix V.
• Primary Examiner(s): Punnoose; Roy M
• Application Number:
  US11/026,387
• Publication Number:
  US 20060146317A1
• Time in Patent Office: 1,181 Days
• Field of Search: 356/128, 356/130, 356/132, 356/136
• US Class Current: 356/128
• CPC Class Codes: B82Y 15/00 Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
• CPC Class Codes: B82Y 30/00 Nanotechnology for materials or surface science, e.g. nanocomposites
• CPC Class Codes: G01N 33/54373 involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings

Abstract

The present invention features use of evanescent field sensing to detect or evaluate unpurified, unlabeled analytes in raw samples. Capture molecules capable of binding to an analyte of interest can be immobilized to a sensing surface of an evanescent field sensor. The interaction between the analyte of interest in a raw sample and the immobilized capture molecules alters the refractive index at the sensing surface, thereby producing a detectable signal in the reflected light from the surface. Raw samples amenable to the present invention include, but are not limited to, cell lysates, tissue extracts, bodily fluid, or biologically-derived samples. Evanescent field sensors suitable for the present invention include, but are not limited to, grating-coupled waveguides.

Claims

1. A method for evaluating interactions between an analyte of interest and a capture molecule, said method comprising:

contacting a liquid raw sample with a sensing surface of an evanescent field sensor, wherein the liquid raw sample comprises the analyte of interest, and the sensing surface is coated with the capture molecule; and

detecting a change in refractive index at the sensing surface, wherein the change in the refractive index indicates whether the analyte of interest interacts with the capture molecule,

wherein the liquid raw sample is selected from the group consisting of a lysate, a supernatant of cultured cells, a bodily fluid, and a tissue extract, and the analyte is selected from the group consisting of a recombinant protein expressed by the cultured cells, a pathogen marker, an antibody specific to the pathogen marker, and a cancer cell marker.

2. The method of claim 1, wherein the evanescent field sensor comprises at least one grating-coupled waveguide.

3. The method of claim 2, wherein detecting a change in refractive index comprises:

contacting a liquid control sample with the sensing surface;

detecting a baseline change in refractive index at the sensing surface; and

comparing the refractive index change produced by the liquid raw sample to the baseline change, wherein the liquid control sample is a lysate or supernatant of culture cells that do not express the recombinant protein.

4. The method of claim 2, wherein detecting a change in refractive index comprises:

directing a light beam into said grating-coupled waveguide, wherein the light beam diffracts to produce an evanescent tail that extends beyond the sensing surface;

receiving a reflected light beam from the grating-coupled waveguide; and

detecting a resonant condition that indicates whether the analyte of interest is bound to the capture molecule.

5. The method of claim 2, wherein said grating-coupled waveguide comprises:

a substrate having a refractive index of no more than 1.5,

a diffraction grating, and

a waveguide film comprising said sensing surface, wherein said waveguide film has a higher refractive index than the substrate.

6. A method for evaluating molecular interactions, comprising:

contacting a plurality of liquid raw samples with respective sensing surfaces of an evanescent field sensor, wherein each liquid raw sample comprises an analyte of interest, and each sensing surface is coated with a capture molecule; and

detecting a change in refractive index at each sensing surface, wherein the change in the refractive index at each sensing surface after being contacted with each liquid raw sample is indicative of whether the analyte of interest in that liquid raw sample interacts with the capture molecule coated at each sensing surface, wherein the liquid raw sample is selected from the group consisting of a lysate, a supernatant of cultured cells, a body fluid sample, and a tissue extract, and the analyte is selected from the group consisting of a recombinant protein expressed by the cultured cells, a pathogen marker, an antibody specific to the pathogen marker, and a cancer cell marker.

7. The method of claim 6, wherein the evanescent field sensor comprises a microplate which includes a plurality of wells, each well comprising a grating-coupled waveguide that includes at least one sensing surface.

8. The method of claim 7, wherein the grating-coupled waveguide in each said well comprises:

a substrate having a refractive index of no more than 1.5;

a diffraction grating; and

a waveguide film comprising one said sensing surface,

wherein said waveguide film has a higher refractive index than the substrate.

9. A method for detecting the presence or absence of an analyte of interest in a liquid raw sample, said method comprising:

contacting said raw sample with a sensing surface of an evanescent field sensor, the sensing surface being coated with capture molecules capable of binding to the analyte of interest; and

detecting a change in refractive index at the sensing surface, wherein the change in the refractive index after the contacting is indicative of the presence or absence of the analyte of interest in the liquid raw sample, wherein the liquid raw sample is selected from the group consisting of a lysate, a supernatant of cultured cells, a body fluid sample, a food sample, a beverage sample, an environmental sample, and a tissue extract, and the analyte is selected from the group consisting of a recombinant protein expressed by the cultured cells, a toxin, a pathogen, a pathogen marker, an antibody specific to the pathogen marker, and a cancer cell marker.

10. The method of claim 9, wherein the evanescent field sensor comprises at least one grating-coupled waveguide.

11. The method of claim 10, wherein said grating-coupled waveguide comprises:

a substrate having a refractive index of no more than 1.5,

a diffraction grating, and

a waveguide film comprising said sensing surface,

wherein said waveguide film has a higher refractive index than the substrate.

12. The method of claim 9, wherein the antibody is an antibody specific to an epitope of a pathogen, and the capture molecules comprise the epitope.

13. The method of claim 12, wherein said pathogen is a virus or a bacterium.

14. The method of claim 9, wherein the analyte is a cancer cell marker, and the capture molecules are antibodies specific to the cancer cell marker.

15. The method of claim 9, wherein detecting a change in refractive index comprises:

directing a light beam into the grating-coupled waveguide, wherein the light beam diffracts to produce an evanescent tail that extends beyond the sensing surface;

receiving a reflected light beam from said grating-coupled waveguide; and

detecting a resonant condition that indicates whether the analyte of interest is bound to the capture molecules.

16. A method for identifying binding partners of a target molecule, the method comprising:

contacting a liquid raw sample with a sensing surface of an evanescent field sensor, wherein the sensing surface is coated with the target molecule, and the liquid raw sample includes a molecule of interest; and

detecting a change in refractive index at the sensing surface, wherein the change in the refractive index in the presence of the liquid raw sample, as compared to that in the presence of a liquid control sample that does not include the molecule of interest, is indicative of whether the target molecule is capable of interacting with the molecule of interest, wherein the liquid raw sample is selected from the group consisting of a lysate, a supernatant of cultured cells, a body fluid sample, and a tissue extract, and the analyte is selected from the group consisting of a recombinant protein expressed by the cultured cells,

a pathogen marker,

an antibody specific to the pathogen marker, and

a cancer cell marker.

17. The method of claim 16, wherein the evanescent field sensor includes one or more grating-coupled waveguides, each said grating-coupled waveguide comprising:

a substrate;

a diffraction grating; and

a waveguide film that comprises an evanescent field sensing surface.

18. The method of claim 17, wherein the substrate has a refractive index of no more than 1.5, and the waveguide film has a higher refractive index than the substrate.